Citrage
Cr├⌐teil · Founded 2009
About Citrage
Citrage is a research and development company in the field of health nutrition. In partnership with Paris Descartes University, Citrage develops dietary supplements and oral nutritional supplements for people over 50 years old. The two main products are 100% L-Citrulline, a nonprotein amino acid that has a direct effect on muscle protein synthesis, optimizing the use of other amino acids and improving muscle maintenance. MyoCIT is a dietary supplement to preserve muscle capital during aging. It is intended for young seniors in the prevention of age-related muscle wasting (causing loss of tone, dynamism, increased fatigue) and to those wishing to remain active, to preserve their quality of life. ProteoCIT is an ADDFMS for use in frail elderly people for the prevention or treatment of undernutrition and sarcopenia. In other words, Citrage helps preserve autonomy and quality of life.
Company Facts
- Founded: 2009
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $54.3K
- Last round: Grant (Mar 2016)
- Website: citrage.com
- Phone: +33 9 81 15 47 56
Social Profiles
Canonical: https://fsome.com/organization/citrage-8364165 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.